Literature DB >> 17934234

The coantioxidative effects of carboxyethyl-6-hydroxychromans and alpha-Tocopherol.

Harumi Uto-Kondo1, Chikako Kiyose, Reiko Ohmori, Hisako Saito, Chie Taguchi, Yoshimi Kishimoto, Naoko Machida, Maiko Hasegawa, Eri Yoshioka, Emi Saita, Yumiko Hirata, Osamu Igarashi, Kazuo Kondo.   

Abstract

alpha-Tocopherol (alpha-Toc) is abundant in LDL and thought to prevent the oxidation of LDL together with various water-soluble antioxidants. Recently, it was reported that alpha-Toc and gamma-Toc metabolites, alpha-carboxyethyl-6-hydroxychromans (CEHC) and gamma-CEHC, are water-soluble antioxidants. In this study, we investigated the interaction between alpha-Toc and CEHC against 1,1-diphenyl-2-picryl-hydrazyl (DPPH) radicals and LDL oxidation. We administered 600 mg of alpha-Toc to healthy male volunteers to obtain LDL including high levels of alpha-Toc before antioxidant administration. The alpha-Toc content of their LDL was increased after consumption at 24 h (18.3 microg/mL) above the level before consumption (6.6 microg/mL). The lag time of LDL at 24 h after alpha-Toc consumption (alpha-Toc rich LDL) with alpha-CEHC (98.5+/-8.2 min) or gamma-CEHC (101.3+/-9.0 min) was longer than that of only alpha-Toc-rich LDL (78.1+/-9.0 min). Furthermore, we examined the interaction of LDL with CEHC and alpha-Toc in vitro (5-20 microg/mL). The lag times of 5 and 10 microg/mL alpha-Toc were 65.5+/-18.9 min and 69.5+/-15.5 min, and that of 20 microg/mL alpha-Toc (83.5+/-20.2 min) was longer than the control value (55.7+/-14.1 min). The lag time of 20 microg/mL alpha-Toc with alpha-CEHC (98.7+/-25.7 min) or gamma-CEHC (100.6+/-25.3 min) was longer than that of only alpha-Toc (83.5+/-20.2 min). These results suggest that CEHC has the potential to delay the oxidation of LDL, while enhancing the antioxidative activity of alpha-Toc both in vitro and ex vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934234     DOI: 10.3177/jnsv.53.301

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  5 in total

Review 1.  Update on Vitamin E and Its Potential Role in Preventing or Treating Bronchopulmonary Dysplasia.

Authors:  Cosby A Stone; Cindy T McEvoy; Judy L Aschner; Ashudee Kirk; Christian Rosas-Salazar; Joan M Cook-Mills; Paul E Moore; William F Walsh; Tina V Hartert
Journal:  Neonatology       Date:  2018-03-07       Impact factor: 5.106

2.  Changes in the concentrations of vitamin E analogs and their metabolites in rat liver and kidney after oral administration.

Authors:  Chikako Kiyose; Kazuki Saito; Rieko Yachi; Chie Muto; Osamu Igarashi
Journal:  J Clin Biochem Nutr       Date:  2015-01-20       Impact factor: 3.114

Review 3.  The Role of Tocotrienol in Protecting Against Metabolic Diseases.

Authors:  Kok-Lun Pang; Kok-Yong Chin
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.411

Review 4.  Vitamin E Metabolic Effects and Genetic Variants: A Challenge for Precision Nutrition in Obesity and Associated Disturbances.

Authors:  Sebastià Galmés; Francisca Serra; Andreu Palou
Journal:  Nutrients       Date:  2018-12-04       Impact factor: 5.717

Review 5.  Regulatory metabolites of vitamin E and their putative relevance for atherogenesis.

Authors:  Maria Wallert; Lisa Schmölz; Francesco Galli; Marc Birringer; Stefan Lorkowski
Journal:  Redox Biol       Date:  2014-02-19       Impact factor: 11.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.